Electromedical Technologies, Inc (EMED): Cash & Equivalents
Not updated since 2023-12-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.
$87.7K
As of 2023-12-31
$34.8K
As of 2024-09-30
-30.8%
3-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2023-12-31 | $87.7K | -76.2% | 2024-05-01, Balance as of period end |
| 2022-12-31 | $368.4K | -3.8% | 2024-05-01, Balance as of period end |
| 2021-12-31 | $383.2K | +44.6% | 2023-03-31, Balance as of period end |
| 2020-12-31 | $264.9K | n/a | 2022-03-31, Balance as of period end |
| 2019-12-31 | $0 | n/a | 2021-03-30, Balance as of period end |